 Lipoproteins
"Lipoproteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes.
| Descriptor ID |
D008074
|
| MeSH Number(s) |
D10.532 D12.776.521
|
| Concept/Terms |
Lipoproteins- Lipoproteins
- Lipoprotein
- Circulating Lipoproteins
- Lipoproteins, Circulating
|
Below are MeSH descriptors whose meaning is more general than "Lipoproteins".
Below are MeSH descriptors whose meaning is more specific than "Lipoproteins".
This graph shows the total number of publications written about "Lipoproteins" by people in this website by year, and whether "Lipoproteins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 1 | 1 | 2 | | 1992 | 3 | 1 | 4 | | 1993 | 0 | 1 | 1 | | 1997 | 1 | 2 | 3 | | 1998 | 4 | 1 | 5 | | 1999 | 2 | 2 | 4 | | 2000 | 4 | 1 | 5 | | 2002 | 0 | 2 | 2 | | 2003 | 3 | 4 | 7 | | 2004 | 0 | 1 | 1 | | 2005 | 1 | 4 | 5 | | 2006 | 1 | 2 | 3 | | 2007 | 3 | 6 | 9 | | 2008 | 4 | 1 | 5 | | 2009 | 0 | 3 | 3 | | 2010 | 2 | 7 | 9 | | 2011 | 0 | 2 | 2 | | 2012 | 3 | 3 | 6 | | 2013 | 3 | 2 | 5 | | 2014 | 2 | 3 | 5 | | 2015 | 4 | 3 | 7 | | 2016 | 1 | 3 | 4 | | 2017 | 3 | 1 | 4 | | 2018 | 1 | 1 | 2 | | 2019 | 3 | 2 | 5 | | 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Lipoproteins" by people in Profiles.
-
D Bruce K, Tang M, Reigan P, H Eckel R. Genetic Variants of Lipoprotein Lipase and Regulatory Factors Associated with Alzheimer's Disease Risk. Int J Mol Sci. 2020 Nov 06; 21(21).
-
Kelly CB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Basu A, Hammad SM, Aston CE, Lyons TJ. Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women With Type 1 Diabetes. J Clin Endocrinol Metab. 2019 10 01; 104(10):4743-4755.
-
Al-Ozairi E, Rivard CJ, Sanchez Lozada LG, Lanaspa MA, Bjornstad P, Al Salem D, Alhubail A, Megahed A, Kuwabara M, Johnson RJ, Asad RA. Fructose tolerance test in obese people with and without type 2 diabetes. J Diabetes. 2020 Mar; 12(3):197-204.
-
Kavanaugh JS, Flack CE, Lister J, Ricker EB, Ibberson CB, Jenul C, Moormeier DE, Delmain EA, Bayles KW, Horswill AR. Identification of Extracellular DNA-Binding Proteins in the Biofilm Matrix. mBio. 2019 06 25; 10(3).
-
Pirim D, Radwan ZH, Wang X, Niemsiri V, Hokanson JE, Hamman RF, Feingold E, Bunker CH, Demirci FY, Kamboh MI. Apolipoprotein E-C1-C4-C2 gene cluster region and inter-individual variation in plasma lipoprotein levels: a comprehensive genetic association study in two ethnic groups. PLoS One. 2019; 14(3):e0214060.
-
Plaks JG, Kaar JL. Lipoic Acid Ligase-Promoted Bioorthogonal Protein Modification and Immobilization. Methods Mol Biol. 2019; 2012:279-297.
-
Yalamanoglu A, Deuel JW, Hunt RC, Baek JH, Hassell K, Redinius K, Irwin DC, Schaer DJ, Buehler PW. Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease. . 2018 11 01; 315(5):L765-L774.
-
Palmisano BT, Zhu L, Eckel RH, Stafford JM. Sex differences in lipid and lipoprotein metabolism. Mol Metab. 2018 09; 15:45-55.
-
El Kasmi KC, Vue PM, Anderson AL, Devereaux MW, Ghosh S, Balasubramaniyan N, Fillon SA, Dahrenmoeller C, Allawzi A, Woods C, McKenna S, Wright CJ, Johnson L, D'Alessandro A, Reisz JA, Nozik-Grayck E, Suchy FJ, Sokol RJ. Macrophage-derived IL-1ß/NF-?B signaling mediates parenteral nutrition-associated cholestasis. Nat Commun. 2018 04 11; 9(1):1393.
-
Yu T, Sungelo MJ, Goldberg IJ, Wang H, Eckel RH. Streptozotocin-Treated High Fat Fed Mice: A New Type 2 Diabetes Model Used to Study Canagliflozin-Induced Alterations in Lipids and Lipoproteins. Horm Metab Res. 2017 May; 49(5):400-406.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|